Table 2.
Comparison of HDL components in non-diabetic subjects and T2DM patients
| Characteristics | All | Female | Male | |||
|---|---|---|---|---|---|---|
| Non-diabetic | T2DM | Non-diabetic | T2DM | Non-diabetic | T2DM | |
| N in category | 298 | 300 | 149 | 150 | 149 | 150 |
| Cholesterol (mg/dL) | 53.8 (13.3) | 46.8 (12.3)§ | 54.6 (12.8) | 49.8 (9.7)ǂ | 52.9 (13.88) | 43.8 (13.9)§ |
| ApoA-I (μg/mL) | 7.8 (2.2) | 6.8 (2.6)§ | 7.5 (2.0) | 6.9 (2.6)ł | 8.0 (2.4) | 6.9 (2.6)ǂ |
| Serum amyloid A (μg/L) | 811.9 (286.8) | 928.5 (326.8)§ | 924.8 (265.3) | 1021.9 (335.2)* | 691.6 (244.4) | 836.0 (291.0)§ |
| Phospholipid (pg/mL) | 963.8 (438.4) | 1080.5 (391.1)ǂ | 992.4 (413.8) | 1045.9 (349.6) | 933.6 (462.3) | 1115.1 (427.0)ǂ |
| sphingosine-1-phosphate (nmol/L) | 1549.7 (473.3) | 1464.3 (699.9) | 1465.0 (450.5) | 1429.4 (769.2) | 1629.3 (480.2) | 1499.3 (623.6)* |
| Triglycerides (log, mg/dl) | 13.6 (10.8–16.4) | 13.0 (10.6–17.6) | 12.3 (9.7–16.0) | 15.0 (11.4–19.4)ǂ | 14.0 (11.7–16.8) | 11.8 (9.4–15.0) |
§ p < 0.0001;ǂ p < 0.001; ł p < 0.01; * p < 0.05 when compared with non-diabetic controls